搜尋結果
How Drug Companies Stifle Competition With ‘Product Hopping’
Forbes· 3 日前In 2014, drugmaker Forest Laboratories and its parent, Actavis, had a $28 billion problem. ...
clichéd 相關
廣告
In 2014, drugmaker Forest Laboratories and its parent, Actavis, had a $28 billion problem. ...